Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis: a Single-arm, Prospective Study

NCT04420130 is registered in ClinicalTrials.gov with Yanqiao Zhang as lead sponsor.

NCT NCT04420130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis: a Single-arm, Prospective Study
Lead sponsor
Yanqiao Zhang
Phase
Not applicable
Overall status
Withdrawn
Start date
August 1, 2020
Completion date
August 1, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastasis, pancreatic cancer